Top ▲

Immune checkpoint proteins

Overview

Click here for help

« Hide More detailed introduction go icon to follow link

Immune checkpoint pathway blockade has revolutionized cancer treatment for some patients, with targeted immunotherapies including ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab, and avelumab making it to the clinic.

How to cite this family page

Database page citation:

Immune checkpoint proteins. Accessed on 24/10/2021. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=954.

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, Striessnig J, Davies JA; CGTP Collaborators. (2019) The Concise Guide to PHARMACOLOGY 2019/20: Introduction and Other Protein Targets. Br J Pharmacol. 176 Issue S1: S1-S20.